ClinicalTrials.Veeva

Menu

REEV SENSE for Gait Analysis in Post-stroke Gait Impairment (SENS-AG)

R

REEV LLC

Status

Enrolling

Conditions

Stroke
Gait Disorders, Neurologic

Treatments

Device: Motion capture system
Device: REEV SENSE

Study type

Interventional

Funder types

Industry

Identifiers

NCT06234878
REEV-RS-01

Details and patient eligibility

About

The purpose of this study is to evaluate the clinical performance of the investigational REEV SENSE gait tracker to measure gait features in subjects with post-stroke gait impairment.

REEV SENSE is intended to be used by trained healthcare professionals as a simple procedure adapted to clinical routine.

The reference method for performance comparison will be motion capture.

Full description

REEV SENSE is a medical device, with pending FDA and CE certifications in class 1. It is a connected gait tracker set primarily on the leg or foot, and eventually on lower limb locations. It contains an accelerometer, a certified standard battery and motion analysis algorithms that will rapidly compute easy-to-use walking analyses accessible to healthcare professionals on a mobile app.

Standard gait biomarkers such as velocity, stride length, or stance and swing times will be computed. However, REEV has also developed a new biomarker, the knee position predictor (KPP), which will provide a more accurate quantification of each individual gait profile.

The present REEV SENSE study is the first to test subjects with a pathological context, i.e. with post-stroke ambulation deficit. Performance of REEV SENSE has already been established in healthy volunteers in comparison to the reference motion capture system, indicating good technical and metrological performance.

The study will take place at the MIT Center for Clinical and Translational Research (CCTR), a reference center with a fully equipped gait lab.

Each participating volunteer will be equipped with REEV SENSE and the reference motion capture system. The participant will be asked to walk at a comfortable self selected pace for about 15 minutes back and forth along a 10m walkway. He or she may rest at any time during the walking session. REEV SENSE and motion capture data will be recorded automatically and simultaneously during the same walking session.

Enrollment

40 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Post-stroke gait disorder.
  • Must be able to walk independently with or without the support of a cane or rollator.
  • History of stroke more than six months ago.
  • Be 18 years of age or older.

Exclusion criteria

  • Subject unable to give consent.
  • Subject unable to understand the tests.

Trial design

Primary purpose

Diagnostic

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

40 participants in 1 patient group

Gait analysis
Experimental group
Description:
Gait analysis with the investigational and the reference devices
Treatment:
Device: REEV SENSE
Device: Motion capture system

Trial contacts and locations

1

Loading...

Central trial contact

Amaury Ciurana, MS

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems